Rockwell Medical Files 2025 Proxy Statement
Ticker: RMTI · Form: DEF 14A · Filed: Apr 14, 2025 · CIK: 1041024
| Field | Detail |
|---|---|
| Company | Rockwell Medical, Inc. (RMTI) |
| Form Type | DEF 14A |
| Filed Date | Apr 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Rockwell Medical's 2025 proxy statement is out, shareholders vote May 20.
AI Summary
Rockwell Medical, Inc. filed a Definitive Proxy Statement (DEF 14A) on April 14, 2025, for its annual meeting on May 20, 2025. The filing details information for shareholders regarding the company's operations and governance, including matters to be voted on at the meeting. Rockwell Medical, Inc. is headquartered in Wixom, Michigan.
Why It Matters
This filing provides shareholders with crucial information to make informed voting decisions on company matters, impacting corporate governance and future strategic direction.
Risk Assessment
Risk Level: low — This is a routine annual filing providing information to shareholders, not indicating new risks.
Key Numbers
- 20250520 — Meeting Date (Annual meeting date for shareholder votes.)
- 20250414 — Filing Date (Date the proxy statement was filed with the SEC.)
Key Players & Entities
- Rockwell Medical, Inc. (company) — Registrant
- 0001041024 (company) — Central Index Key
- 30142 WIXOM ROAD (company) — Business Address
- WIXOM (company) — City
- MI (company) — State
- 48393 (company) — ZIP Code
- 8004493353 (company) — Business Phone
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit proxies from shareholders for an upcoming shareholder meeting, providing detailed information about matters to be voted upon.
When is the Rockwell Medical, Inc. shareholder meeting scheduled?
The shareholder meeting for Rockwell Medical, Inc. is scheduled for May 20, 2025.
When was this DEF 14A filing submitted?
This DEF 14A filing was submitted on April 14, 2025.
What is Rockwell Medical, Inc.'s primary business classification?
Rockwell Medical, Inc. is classified under Pharmaceutical Preparations [2834].
Where is Rockwell Medical, Inc. headquartered?
Rockwell Medical, Inc. is headquartered at 30142 Wixom Road, Wixom, MI 48393.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 14, 2025 regarding ROCKWELL MEDICAL, INC. (RMTI).